Annual report pursuant to Section 13 and 15(d)

Share Capital (Tables)

v3.24.1
Share Capital (Tables)
 12 Months Ended
Dec. 31, 2023
Share Capital [Line Items]  
Schedule of Outstanding Stock Options A continuity schedule of outstanding stock options is as follows:
    Number
Outstanding		     Weighted
Average
Exercise
Price		  
          ($)  
Balance – December 31, 2021     8,091       1,017.60  
Granted     6,533       99.04  
Exercised     -       -  
Forfeited     (386 )     1,484.96  
Balance – December 31, 2022     14,238       594.08  
Granted     25,000       14.40  
Exercised     -       -  
Forfeited     (10,247 )     392.60  
Balance – December 31, 2023     28,990       165.38  
Schedule of Assumptions For Fair Value of Stock Options The Company used the following assumptions in calculating the fair value of stock options for the period ended:
    December 31,
2023		     December 31,
2022		  
Risk-free interest rate     3.93%     2.14% – 4.03%  
Expected life of options     3.69 years       5.0 years  
Expected dividend yield     Nil       Nil  
Volatility     132.65%     96.90% – 112.40%  

 
Schedule of Share Purchase Warrants Outstanding At December 31, 2023, the Company had incentive stock options outstanding as follows:
Expiry Date  

Options

Outstanding

    

Exercise

Price 

     Weighted Average
Remaining Life		  
          ($)     (years)  
April 2, 2024     432       604.80       0.25  
June 27, 2024     26       614.40       0.49  
September 27, 2024     962       1,087.20       0.74  
October 22, 2024     52       967.20       0.81  
July 24, 2025     556       715.20       1.56  
July 31, 2025     546       715.20       1.58  
August 10, 2025     52       715.20       1.61  
June 1, 2026     236       1,689.60       2.42  
June 29, 2026     44       1,356.00       2.50  
August 19, 2026     1,501       1,008.00       2.64  
May 10, 2027     13       189.60       3.36  
August 17, 2027     3,212       96.00       3.63  
September 20, 2027     140       55.20       3.72  
February 13, 2028     21,218       14.40       4.12  
      28,990       165.38       3.69  
Warrant [Member]  
Share Capital [Line Items]  
Schedule of Outstanding Stock Options A continuity schedule of outstanding share purchase warrants is as follows:
    Number Outstanding     Weighted Average Exercise Price  
          ($)  
Balance –  December 31, 2021     18,692       1,639.20  
Exercised     -       -  
Expired     (11,662 )     1,540.80  
Issued     322,878       54.72  
Balance – December 31, 2022     329,908       91.84  
Exercised     (283,875 )     16.19  
Expired     -       -  
Issued     850,612       3.83  
Balance – December 31, 2023(1)     896,645       32.36  
(1) Unit A warrant balance is 7,030 as of December 31, 2023 and 2022.
Schedule of Assumptions For Fair Value of Stock Options The Company used the following assumptions in calculating the fair value of the warrants for the period ended:
    December 31,
2023		     December 31,
2022		  
Risk-free interest rate     4.13% - 4.49%       3.99% - 4.22%  
Expected life of warrants     2.06 – 4.80 years       3.06 – 5.05 years  
Expected dividend yield     Nil       Nil  
Volatility     132.78%     119% – 124.9%  
Weighted average fair value per warrant   $4.69     $4.16  
Schedule of Share Purchase Warrants Outstanding At December 31, 2023, the Company had share purchase warrants outstanding as follows:
Expiration Date  

Warrants

Outstanding

    

Exercise

Price

     Weighted Average Remaining Life  
          ($)     (years)  
January 20, 2026(1)     7,030       1,800.00       2.06  
February 28, 2027     20,689       460.80       3.16  
December 6, 2027     13,781       20.00       3.93  
December 9, 2027     9,876       17.60       3.94  
January 18, 2028     25,906       124.80       4.05  
February 2, 2028     10,938       14.40       4.10  
October 17, 2028     783,968       3.68       4.80  
October 17, 2028     24,457       4.05       4.80  
      896,645       32.36       4.69  
(1) Unit A warrant balance is 7,030 as of December 31, 2023 and 2022.